secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hepion Pharmaceuticals, Inc. (HEPA)
CIK:        0001583771
Form:       8-K
Filed at:   2024-12-11T23:59:59+00:00
Accession:  0001493152-24-049561
Event type: other_material
Sentiment:  negative
Materiality: 0.80
Item codes: 1.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hepion terminates merger with Pharma Two B; special meeting cancelled
---------------------------------------------------------------------

- Merger Agreement with Pharma Two B Ltd. terminated mutually on Dec 10, 2024.
- No termination fee payable by either party.
- Special stockholders meeting scheduled for Dec 12, 2024 cancelled; proposals withdrawn.
- Nasdaq would not exclude historical losses from burn-rate calculation, leading to termination.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583771/000149315224049561/0001493152-24-049561-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583771/000149315224049561/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-049561

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer